145 related articles for article (PubMed ID: 38126313)
1. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
2. [Drug glucuronidation and disposition in brain].
Zhang ZQ; Sheng L; Li Y
Yao Xue Xue Bao; 2016 Nov; 51(11):1674-80. PubMed ID: 29908109
[TBL] [Abstract][Full Text] [Related]
3. Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine.
Heikkinen AT; Friedlein A; Matondo M; Hatley OJ; Petsalo A; Juvonen R; Galetin A; Rostami-Hodjegan A; Aebersold R; Lamerz J; Dunkley T; Cutler P; Parrott N
Pharm Res; 2015 Jan; 32(1):74-90. PubMed ID: 25033762
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
[TBL] [Abstract][Full Text] [Related]
5. Rapid and convenient biotransformation procedure for human drug metabolizing enzymes using permeabilized fission yeast cells.
Sharma S; Durairaj P; Bureik M
Anal Biochem; 2020 Oct; 607():113704. PubMed ID: 32697953
[TBL] [Abstract][Full Text] [Related]
6. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
[TBL] [Abstract][Full Text] [Related]
7. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
Kim SB; Kim KS; Kim DD; Yoon IS
Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
[TBL] [Abstract][Full Text] [Related]
8. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
Knights KM; Rowland A; Miners JO
Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
[TBL] [Abstract][Full Text] [Related]
9. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
[TBL] [Abstract][Full Text] [Related]
10. Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex.
Ishii Y; Iwanaga M; Nishimura Y; Takeda S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
Drug Metab Pharmacokinet; 2007 Oct; 22(5):367-76. PubMed ID: 17965520
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human.
Basit A; Neradugomma NK; Wolford C; Fan PW; Murray B; Takahashi RH; Khojasteh SC; Smith BJ; Heyward S; Totah RA; Kelly EJ; Prasad B
Mol Pharm; 2020 Nov; 17(11):4114-4124. PubMed ID: 32955894
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory and Inductive Effects of
Jeong H; Kim S; Kim MY; Lee J; An BH; Kim HD; Jeong H; Song YS; Chang M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380747
[No Abstract] [Full Text] [Related]
13. Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain.
Stocco MR; Tyndale RF
Adv Pharmacol; 2022; 95():73-106. PubMed ID: 35953164
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues.
Zhou L; Montalvo AD; Collins JM; Wang D
Pharmacol Res Perspect; 2023 Dec; 11(6):e01154. PubMed ID: 37983911
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes.
Kong TY; Kim JH; Kim DK; Lee HS
Arch Pharm Res; 2018 Jul; 41(7):691-710. PubMed ID: 30039377
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro Systems.
Wheeler AM; Orsburn BC; Bumpus NN
Drug Metab Dispos; 2023 Apr; 51(4):521-531. PubMed ID: 36623884
[TBL] [Abstract][Full Text] [Related]
19. Significantly decreased and more variable expression of major CYPs and UGTs in liver microsomes prepared from HBV-positive human hepatocellular carcinoma and matched pericarcinomatous tissues determined using an isotope label-free UPLC-MS/MS method.
Yan T; Gao S; Peng X; Shi J; Xie C; Li Q; Lu L; Wang Y; Zhou F; Liu Z; Hu M
Pharm Res; 2015 Mar; 32(3):1141-57. PubMed ID: 25288013
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Mammalian UDP-Glucuronosyltransferases.
Wang H; Cao G; Wang G; Hao H
Curr Drug Metab; 2018; 19(6):490-501. PubMed ID: 29521218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]